Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

High-level Texas delegation visits UFS
2010-08-13

Pictured here, from the left, back, are visitors from Texas and UFS management: Ms Stephanie Curs (Director: Office of the Vice President for Global Initiatives), Dr Edwin Price (Associate Vice-Chancellor for International Agriculture and Director of the Norman Borlaug Institute for International Agriculture), Dr Mike Greenwald (Professor and Program Director for the International Studies Program, College of Liberal Arts), Prof. Ward Wells (Professor and Associate Head for Professional Programs, College of Architecture, and Director of Academy for Visual and Performing Arts), Dr Glen Mills ( Professor and Head of Department of Architecture), and Dr Alan Sams (Executive Associate Dean, College of Agriculture and Life Sciences); front: Prof. Jonathan Jansen (Rector and Vice-Chancellor, UFS), Mr Eric Bost (former USA Ambassador to South Africa and Vice-President for Global Initiatives), and Prof. Ezekiel Moraka (Vice-Rector: External Relations, UFS). – Photo: Stephen Collett.

A high-level delegation from Texas A&M University in the USA, led by Mr Eric Bost, Vice-President Global Initiatives and previous USA Ambassador to South Africa, visited the University of the Free State (UFS) recently. The objective of the visit was to forge strategic linkages and research partnerships within the ambit of Texas A&M’s expanded Africa strategy.

Texas A&M has 50 000 students, and is internationally renowned and highly rated for its scholarship, academic achievement and excellent research profile. The delegation consisted of representatives from the President's Office, various deans and heads of departments.

The discussions during the visit identified a number of shared interests and common research foci, and colleagues were unanimous in their pursuit to strengthen the relations.

In January 2009 Mr Bost delivered his final official address as US Ambassador to South Africa on the UFS Main Campus. Mr Bost, a close friend of the UFS, has since sparked numerous activities to further the transformation agenda at the UFS, and is very supportive of the work of the International Institute for Race, Reconciliation and Social Justice. A number of Fulbright senior specialists from the US are participating in the further conceptualisation, roll-out and activities of the Institute.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept